NKE vs PAHC · P/E 35, rev $46.40B vs P/E 13, rev $1.52B
Nike Inc (NKE) versus Phibro Animal Health Corporation (PAHC) — a side-by-side from cached financials, not a winner call.
Nike Inc (NKE) is a footwear & accessories company listed on US. It is led by Elliott J. Hill.
Phibro Animal Health Corporation (PAHC) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported NKE revenue for 2026-05-31 was $46.40B. Net income was $3.11B. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
Latest reported PAHC revenue for 2026-06-30 was $1.52B. Net income was $99.7M. Revenue was up 17.1% from 2025-06-30 to 2026-06-30. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
NKE currently screens at market cap $110.14B and trailing P/E 34.6. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
Not investment advice. Open the NKE and PAHC stock pages for the full models.
Not investment advice.